Use of F-18 Fluorodeoxyglucose Positron Emission Tomography With Dual-Phase Imaging to Identify Intraductal Papillary Mucinous Neoplasm

Accuracy of 18F-FDG PET/CT, Multidetector CT, and MR Imaging in the Diagnosis of Pancreatic Cysts: A Prospective Single-Center Study

“…In our study, 18 F-FDG PET/CT had excellent sensitivity of 100% and a good positive predictive value of 75% in the differential diagnosis of malignant and benign pancreatic cystic lesions. Similarly, 18 F-FDG PET/CT has outperformed conventional imaging in all previous studies concerning pancreatic cystic lesions-studies that were conducted on patients with IPMN (10,(18)(19)(20). Recently, Pedrazzoli et al (21) concluded that the decision on whether to perform prophylactic resectioning of IPMN in young patients fit for surgery should be guided by the International Consensus Guidelines (12), whereas PET should be performed in the case of older patients, those at increased surgical risk, and those for whom the feasibility of parenchyma-sparing surgery demands reliable preoperative exclusion of malignancy.…”

Value of apparent diffusion coefficient for predicting malignancy of intraductal papillary mucinous neoplasms of the pancreas

“…[18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography ( 18 F-FDG PET) seems to be valuable for evaluating the malignancy of IPMN of the pancreas (22)(23)(24)(25). Takanami et al (22) found that a 18 F-FDG PET outperformed a contrast enhanced CT for predicting malignant IPMN with mural nodules.…”

CT and MR imaging features of fistulas from intraductal papillary mucinous neoplasms of the pancreas to adjacent organs: A retrospective study of 423 patients

“…Ces tumeurs sont caractérisées par la prolifération de cellules épithéliales papillaires productrices de mucus provoquant une augmentation de la production de mucine et donc, une dilatation des canaux pancréatiques, principal et/ou secondaires (47). Le terme (194)(195)(196), des marqueurs tumoraux sériques et des marqueurs moléculaires.…”